Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis

Completed · Phase 3

Conditions studied: Vasomotor Rhinitis, Rhinitis, Vasomotor

In brief

The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with vasomotor rhinitis (VMR).

Key facts

Study ID

NCT00118703

Run by

GlaxoSmithKline

People needed

350

Starts

2005-07-01

Expected to finish

2006-02-09

Last updated by the study team

2017-08-21

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be outpatients.
• Diagnosis of VMR (vasomotor rhinitis).
• Literate in English or native language.

You may not qualify if…

• Significant concomitant medical condition.
• Use corticosteroids or other allergy medications during the study.
• Used tobacco products within the past year.

Where it is running

• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Fresno, California, United States
• GSK Investigational Site — Irvine, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Paramount, California, United States
• GSK Investigational Site — Sacramento, California, United States
• GSK Investigational Site — San Francisco, California, United States
• GSK Investigational Site — San Jose, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Englewood, Colorado, United States
• GSK Investigational Site — Miami, Florida, United States
• GSK Investigational Site — Sarasota, Florida, United States
• GSK Investigational Site — Tallahassee, Florida, United States
• GSK Investigational Site — Vero Beach, Florida, United States
• GSK Investigational Site — Stockbridge, Georgia, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — South Bend, Indiana, United States
• GSK Investigational Site — Shreveport, Louisiana, United States
• GSK Investigational Site — Bethesda, Maryland, United States
• GSK Investigational Site — Wheaton, Maryland, United States
• GSK Investigational Site — North Dartmouth, Massachusetts, United States
• GSK Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.